- Home
- PVLA vs CSR Comparison
PVLA vs CSR Comparison
Compare PVLA & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PVLA | CSR |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PVLA | CSR |
|---|---|---|
| Price | $82.38 | $64.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 6 |
| Target Price | ★ $145.24 | $70.20 |
| AVG Volume (30 Days) | ★ 243.4K | 118.8K |
| Earning Date | 11-11-2025 | 02-17-2026 |
| Dividend Yield | N/A | ★ 4.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.82 |
| Revenue | N/A | ★ $273,450,000.00 |
| Revenue This Year | N/A | $7.24 |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | ★ N/A | $35.22 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $14.60 | $52.76 |
| 52 Week High | $114.69 | $69.15 |
Technical Indicators
Market Signals| Indicator | PVLA | CSR |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 48.68 |
| Support Level | $74.40 | $63.75 |
| Resistance Level | $83.47 | $65.32 |
| Average True Range (ATR) | 5.91 | 1.17 |
| MACD | -1.09 | -0.01 |
| Stochastic Oscillator | 27.30 | 40.85 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.